Phase 3 trial of nasal spray for treatment of anxiety disorders underway Dr. Kamal Kant Kohli20 April 2022 9:00 AM ISTVistaGen Therapeutics and AffaMed Therapeutics have announced a global phase 3 trial to assess the efficacy, safety and tolerability of a fast-acting...
Strength and difficulties questionnaire may predict behaviour of child during first dental visit Dr. Shravani Dali19 April 2022 9:00 AM ISTPsychological problems influence dental behavior in children. Strength and difficulties questionnaire may predict behaviour of child during first...
Certain psychiatric disorders increase risk of COVID-19 reinfection Dr. Kamal Kant Kohli18 April 2022 9:00 AM ISTA new study led by UC San Francisco has shown that people who are vaccinated against SARS-CoV-2, and have a history of certain psychiatric conditions,...
Sharing nighttime infant care can reduce sleep disturbance in new mothers, study finds Medical Dialogues Editorial Team16 April 2022 9:00 AM ISTAustralia: The amount of nighttime feeds was connected with shorter or worse nocturnal sleep, but not breastfeeding per se, says an article published...
Metacognitive training shows promising outcomes in psychosis cases, JAMA says Medical Dialogues Editorial Team15 April 2022 9:45 AM ISTCanada: In a new study published in JAMA Psychiatry it was seen that in numerous treatment situations, metacognitive training (MCT) for psychosis...
Hyperbaric oxygen therapy shows promise for treatment of opioid addiction Dr. Kamal Kant Kohli13 April 2022 10:45 PM ISTSPOKANE: Wash-Hyperbaric oxygen therapy may help people being treated for opioid addiction reduce their methadone dose and better manage pain and...
Methamphetamine use during pregnancy may increase maternal and neonatal complications Dr Nirali Kapoor13 April 2022 9:00 AM ISTThe use of amphetamine-type stimulants (ATSs) has been increasing among women worldwide. Cases of pregnant mothers with ATS and maternal/fetal...
Amisulpride and olanzapine combo as an alternative to monotherapy in schizophrenia? Study sheds light Medha Baranwal12 April 2022 12:00 PM ISTGermany: The combination of amisulpride and olanzapine therapy could be used in schizophrenia patients as an alternative to monotherapy in certain...
Eye diseases in paediatric population linked with mental illness Medha Baranwal12 April 2022 11:45 AM ISTUSA: A recent study in the American Journal of Ophthalmology has demonstrated an association between eye disease in the pediatric population and...
Journal Club - Brahmi Vati useful in general anxiety disorder Isra Zaman12 April 2022 11:00 AM ISTWith a 3-3.5% prevalence among the adult Indian population, Generalised Anxiety Disorder has become a problem bigger than we may think. According to...
FDA approves dexmedetomidine as a drug for treatment of schizophrenia, bipolar disorder MD Editorial Team11 April 2022 9:00 AM ISTSchizophrenia is a serious mental disorder that results in some combination of hallucinations, delusions, and extremely disordered thinking and...
Brahmi Vati useful in General Anxiety Disorder: Study Isra Zaman9 April 2022 11:30 AM ISTGeneralized Anxiety Disorder is prevalent among the general population as one of the most common and disabling anxiety disorders.Its common symptoms...
